mynth
← DATABASE
04/2025

NEOGEN (ANIMAL BIOSECURITY DIVISION) acquired by KERSIA

UNITED STATES Healthcare Services / Sterilization & Hygiene EV 100M - 350M EUR

Context

Kersia is acquiring the animal biosecurity cleaners and disinfectants business from Neogen® through an exclusive agreement. This strategic transaction marks a major entry for the French group into the North American swine and poultry markets, complementing its existing domestic presence in the ruminant sector. The acquisition is a transformative step for the group, doubling its American activity and positioning it among the top three global players in the agricultural hygiene and disinfection market. The strategy focuses on leveraging the target's extensive product registration portfolio and its three dedicated U.S. manufacturing sites to provide nationwide coverage. This deal also expands the acquirer's international footprint into 20 new countries, particularly in Central America and the Asia-Pacific region, supporting its ambition to become the undisputed global leader in animal biosecurity.

NEOGEN (ANIMAL BIOSECURITY DIVISION), which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Neogen's Animal Biosecurity Division is a major North American division specializing in cleaners and disinfectants for the animal biosecurity market. It is a key player in the swine and poultry sectors, providing specialized hygiene and water treatment solutions. With over 120 employees and an international presence in more than 50 countries—including China, Mexico, Brazil, and Australia—the business holds an extensive portfolio of product registrations and certifications. It operates two strategic manufacturing sites in the United States: one in Memphis (Tennessee), located in the heart of the poultry belt, and another in Turlock (California). The division is recognized for its high-quality biosecurity protocols and critical role in preventing contamination within the livestock industry.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2024
2023

Similar deals in Healthcare Services

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
10/2025EVOLEMAPPERTONFRANCESterilization & Hygiene
05/2025FIVE ARROWSHUBLOFRANCEHealth Tech
04/2025TRANSCARENTACCOLADEUNITED STATESHealth Tech
10/2024FullscriptRupa HealthUNITED STATESHealth Tech
07/2024ARDIANMASCO GROUPITALYHealthcare Services
06/2024PERMIRAPHARMACORDUNITED STATESHealth Tech
05/202421 INVEST / OAKLEY CAPITAL INVESTMENTSPRODUCT LIFEFRANCEHealthcare Services
10/2023MOTION EQUITY PARTNERSBANOOKFRANCECRO / Clinical Trials
09/2023CERBA HEALTHCARECIRION BIOPHARMA RESEARCHCANADACRO / Clinical Trials
09/2023PERMIRAERGOMEDUNITED KINGDOMCRO / Clinical Trials

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of NEOGEN (ANIMAL BIOSECURITY DIVISION) by KERSIA are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: kersia